Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Siegert

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2018
Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosisElise Siegert, Christine March, Lindsey Otten, et al.
Annals of the Rheumatic Diseases|January 23, 2015
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLEJens Y Humrich, Caroline von Spee-Mayer, Elise Siegert, et al.
Rheumatology (Oxford, England)|March 7, 2024
Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosisCharles Midol, Edgar Wiebe, Elise Siegert, et al.
Arthritis Research & Therapy|March 12, 2014
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patientsJeannine Günther, Angela Kill, Mike Oliver Becker, et al.
Zeitschrift Fur Rheumatologie|July 25, 2024
[Interdisciplinary centers for autoimmune diseases in Germany]Margitta Worm, Claudia Günther, Martin Claussen, et al.
Frontiers in Medicine|February 5, 2025
Identification of nuclear valosin-containing-protein-like as a target of anti-nuclear autoantibodies in systemic sclerosisZitao Zeng, Ramona Miske, Madeleine Scharf, et al.
Nature Cell Biology|March 18, 2008
Sirt1 contributes critically to the redox-dependent fate of neural progenitorsTimour Prozorovski, Ulf Schulze-Topphoff, Robert Glumm, et al.
Annals of the Rheumatic Diseases|June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR modelWanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
Acta Neuropathologica|April 17, 2021
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathologyElise Siegert, Akinori Uruha, Hans-Hilmar Goebel, et al.
Annals of the Rheumatic Diseases|September 2, 2015
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusCaroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 2018
Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosisElise Siegert, Christine March, Lindsey Otten, et al.
Annals of the Rheumatic Diseases|January 23, 2015
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLEJens Y Humrich, Caroline von Spee-Mayer, Elise Siegert, et al.
Rheumatology (Oxford, England)|March 7, 2024
Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosisCharles Midol, Edgar Wiebe, Elise Siegert, et al.
Arthritis Research & Therapy|March 12, 2014
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patientsJeannine Günther, Angela Kill, Mike Oliver Becker, et al.
Zeitschrift Fur Rheumatologie|July 25, 2024
[Interdisciplinary centers for autoimmune diseases in Germany]Margitta Worm, Claudia Günther, Martin Claussen, et al.
Frontiers in Medicine|February 5, 2025
Identification of nuclear valosin-containing-protein-like as a target of anti-nuclear autoantibodies in systemic sclerosisZitao Zeng, Ramona Miske, Madeleine Scharf, et al.
Nature Cell Biology|March 18, 2008
Sirt1 contributes critically to the redox-dependent fate of neural progenitorsTimour Prozorovski, Ulf Schulze-Topphoff, Robert Glumm, et al.
Annals of the Rheumatic Diseases|June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR modelWanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
Acta Neuropathologica|April 17, 2021
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathologyElise Siegert, Akinori Uruha, Hans-Hilmar Goebel, et al.
Annals of the Rheumatic Diseases|September 2, 2015
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosusCaroline von Spee-Mayer, Elise Siegert, Dimas Abdirama, et al.
Pageof 8